Findings from two abstracts presented at the American Society for Metabolic & Bariatric Surgery (ASMBS) 2025 Annual Meeting reinforce the role of the AI-powered Allurion Program in delivering ...

Allurion Technologies, Inc, a pioneer in metabolically healthy weight loss, presented two new abstracts at the American Society for Metabolic & Bariatric Surgery (ASMBS) 2025 Annual Meeting. Findings ...

Allurion Technologies, Inc. ("Allurion" or the "Company") (NYSE: ALUR), a pioneer in metabolically healthy weight loss, today announced that Dr. Shantanu Gaur, Founder and Chief Executive Officer, ...

Allurion is a pioneer in metabolically healthy weight loss. The Allurion Program is a weight-loss platform that combines the Allurion Gastric Balloon, the world’s first and only swallowable ...

On Wednesday, 04 June 2025, Allurion Technologies Inc. (NYSE:ALUR) presented at the Jefferies Global Healthcare Conference 2025, unveiling strategic plans for its metabolically healthy weight loss ...

On Wednesday, 04 June 2025, Allurion Technologies Inc. (NYSE:ALUR) presented at the Jefferies Global Healthcare Conference 2025, unveiling strategic plans for its metabolically healthy weight loss ...

NATICK, Mass.--(BUSINESS WIRE)--Allurion Technologies, Inc. (“Allurion” or the “Company”) (NYSE: ALUR), a pioneer in metabolically healthy weight loss, today ...

In 1,962 patients treated in France with the Allurion Program, muscle mass as a percentage of total body weight increased, on average, by 6.6% and fat mass decreased, on average, by 11% Company ...

Detailed price information for Dyne Therapeutics Inc (DYN-Q) from The Globe and Mail including charting and trades.